FDA sent a warning letter , dated Aug. 2, 2019, to Emcure Pharmaceuticals after an inspection of the company s Maharashtra, India facility found that the company had failed to thoroughly test sterility failures. The inspection occurred from Feb. 11 20, 2019.
The letter stated the companOriginal Article
